New study suggests that treating patients for CHIP (clonal growth of precancerous blood cells) could reduce their risk of potentially life-threatening heart inflammation.

The findings could suggest ways to intervene before clinical symptoms of memory and cognitive impairment become apparent.

The collaboration will leverage VUMC’s resource platform, including its comprehensive datasets hosted in Vanderbilt’s BioVU collection of DNA and plasma to enable data-driven insights and to accelerate discovery and development.

The researchers anticipate that their findings will inform personalized colorectal polyp surveillance, guide therapeutic prevention strategies, and ultimately reduce the burden of colorectal cancer nationwide.

Roden is internationally known for his contributions to understanding arrhythmias and to the field of pharmacogenomics.

These raised scars tend to recur after surgical removal, and the effectiveness of alternative treatments is limited.

He received the award for his pioneering work focusing on leveraging genetic information to enhance health care outcomes.